AtriCure (ATRC) Non-Current Debt (2010 - 2026)
AtriCure's (ATRC) quarterly Non-Current Debt came in at $61.0 million in Q2 2026, down 1.4% year-over-year from $61.9 million in Q2 2025, and little changed quarter-over-quarter from $61.0 million in Q1 2026.
Analysis
AtriCure (ATRC) Non-Current Debt (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Non-Current Debt for 16 consecutive years, with $61.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 1.4% year-over-year to $61.0 million in Q2 2026; TTM through Jun 2026 was $61.0 million, a 1.4% decrease from a year earlier, with the FY2025 full-year figure at $61.9 million, changed 0.0% from the prior year.
- Non-Current Debt was $61.0 million for Q2 2026 at AtriCure, roughly flat from $61.0 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $61.9 million in Q1 2024 and troughed at $56.8 million in Q4 2022.
- A 5-year average of $60.8 million and a median of $61.0 million in 2026 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 37.4% in 2022, down 4.87% in 2022.
- Over 5 years, Non-Current Debt stood at $56.8 million in 2022, then increased by 6.61% to $60.6 million in 2023, then gained by 2.1% to $61.9 million in 2024, then changed by 0.0% to $61.9 million in 2025, then dropped by 1.4% to $61.0 million in 2026.
- The last three Non-Current Debt figures came in at $61.0 million (Q2 2026), $61.0 million (Q1 2026), and $61.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.65 Bn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | 61.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.00 Mn |
| Mar 31, 2026 | 61.00 Mn |
| Dec 31, 2025 | 61.87 Mn |
| Sep 30, 2025 | 61.87 Mn |
| Jun 30, 2025 | 61.87 Mn |
| Mar 31, 2025 | 61.87 Mn |
| Dec 31, 2024 | 61.87 Mn |
| Sep 30, 2024 | 61.87 Mn |
| Jun 30, 2024 | 61.87 Mn |
| Mar 31, 2024 | 61.87 Mn |
| Dec 31, 2023 | 60.59 Mn |
| Sep 30, 2023 | 60.00 Mn |
| Jun 30, 2023 | 60.00 Mn |
| Mar 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | 56.83 Mn |
| Sep 30, 2022 | 60.06 Mn |
| Jun 30, 2022 | 60.00 Mn |
| Mar 31, 2022 | 60.00 Mn |
| Dec 31, 2021 | 59.74 Mn |
| Sep 30, 2021 | 60.00 Mn |